← FDA DRUG APPROVALS

FDA ANDA · ANDA077965

NORTRIPTYLINE HYDROCHLORIDE

Sponsor: TARO

APPLICATION
ANDA077965
TYPE
ANDA
ORIGINAL APPROVAL
2006-06-20
LATEST ACTION
2009-02-20
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

NORTRIPTYLINE HYDROCHLORIDEDiscontinued
NORTRIPTYLINE HYDROCHLORIDE EQ 10MG BASE/5ML · SOLUTION · ORAL

Approval history

2009-02-20Labeling · Supplement 2AP
2007-08-03Labeling · Supplement 1AP
2006-06-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →